Healthcare
Inflexion acquires CDMO Upperton
The GP has invested in the British CDMO via its Enterprise Fund V
GBL bags second healthcare asset this week with SBO of Sanoptis
Vendor Telemos to fully exit DACH eye clinics operator following auction that also saw ICG and Ares compete for the asset
KKR makes USD 15bn approach for Ramsay Health Care
European operations of Australia-listed hospital group account for EUR 760m EBITDA
GBL acquires Affidea from B-Flexion
Formerly known as Waypoint, vendor is fulling exiting the pan-European outpatient group; new owner will invest EUR 1bn in equity
EQT pauses LimaCorporate auction
Sponsor is expected to reassess options for the Italian orthopaedic prosthetics producer after new CEO appointment
ICG, Ares and GBL among sponsors in Sanoptis second round
Current backer Telemos wants to remain invested as a minority shareholder in the ophthalmology group
Carlyle acquires life sciences investor Abingworth
Deal follows EQT's acquisition of LSP in November 2021 as asset managers look for greater specialisation
EMZ acquires FotoFinder Systems
EMZ is acquiring a majority stake in the medical imaging company via EMZ 9, which is 80% deployed
Bridgepoint in exclusivity to acquire G Square's Dentego
Mergermarket reported that sponsors including Ardian, BC, Eurazeo and IK showed interest in the asset
Novo-backed ReViral acquired by Pfizer
The British biotech company is also backed by CR-CP, New Leaf, Andera Partners, and OrbiMed, among others
Dental Directory sees Exponent, Equistone bare teeth in sale second round
DC Advisory is expected to review final bids for the carve-out from Palamon-backed IDH Group in about a month
Specialist healthcare funds on track for another record year
GPs raised EUR 4.4bn with swelling need for healthcare investment but could face challenges in keeping a disciplined deployment
AP Moller, Biogroup among final bidders for Waypoint's Affidea
Final offers for the pan-European outpatient group are expected in a couple of weeks
Lightrock announces promotions, board appointments
Impact investor expects to turn its focus to new deals in 2022 and grew its team by 30% in 2021
Summit buys 18 Week Support
Deal for UK-based NHS insourcer confirmed by March 25 Companies House filing; buyout follows Houlihan Lokey-led auction launched last year
CVC sells Theramex to Carlyle, PAI for GBP 1.2bn
CVC acquired the women's health pharmaceutical business in a USD 703m carve-out in 2017
Ardian readies Dedalus for controlling stake sale
Morgan Stanley and UBS are preparing an auction for the Italy-based hospital software group
GHO to explore Sterling Pharma exit this year
UK pharma manufacturing services asset could be marketed off GBP 50m EBITDA in a sale process in H2 2022
Hg gears up for MEDIFOX DAN exit
Houlihan Lokey will advise on the sale of the healthcare software group, which has already seen interest from large sponsors
Jeito, INKEF, Forbion lead EUR 80m Series B for Precirix
Precirix last raised a EUR 37m Series A in 2018
Gilde Healthcare closes fourth buyout fund on EUR 517m
Double the size of its predecessor, the new vehicle was oversubscribed and saw nearly all Gildeтs existing LPs investing
I Asset Management, BaltCap acquire Dr Vet
IAM has a specialist Petcare Growth Fund
Ufenau moves Corius and Altano to continuation fund
Bought in 2017, the dermatology and vet groups have been transferred into the Swiss GP’s third continuation vehicle
Queen's Park Equity backs Blue Ribbon MBO
The deal is the sixth from QPE's Equity Fund I